Boosting Early Detection of Cervical Changes with Light Technology
NCT00900575 · RecruitingThis study looks at how light technology can identify changes in cervical tissue. The goal is to find early signs of cervical cancer. It focuses on the use of optical techniques to detect cervical dysplasia, which is a condition that can lead to cancer.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- Duke University Medical CenterDurham, North CarolinaRecruiting
Who can join
Women aged 18 and older can join the study. This includes those undergoing colposcopy or LEEP for cervical cancer. Women who have recently bled or had preterm labor cannot participate. The team will confirm who is eligible.
What happens during the trial
Participants will use a special light device during their procedures. This includes a bench-top optical spectrometer and a portable spectrometer. Everyone in this study will receive the same treatment to help find optical signatures in cervical tissue. It will take less than 10 minutes during the procedure.
The trial team
Duke University is running this study. Dr. Nimmi Ramanujam is the principal investigator leading the research.
Important dates
The study started in May 2006 and is expected to finish by January 31, 2028. It is currently recruiting new participants.
Additional information
The trial's ID number is NCT00900575. It does not have a specific phase. About 350 people will participate in this study, which is regulated by the FDA.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →